CUREosity and partners launch pilot project for virtual reality therapy
CUREosity and partners launch pilot project for virtual reality therapy
07.02.2024
Since February 1, 2024, the German health insurance company Techniker Krankenkasse has been reimbursing virtual reality therapy (VR therapy) with CUREO® in rehabilitation, making it the first health insurance company in Germany to make this modern therapy method available to its policyholders. The offer is initially aimed at patients of the Ambulanticum, which is the ideal partner for the project.
Patients insured with TK at the Ambulanticum in Herdecke benefit from the cost coverage of CUREosity's virtual reality therapy since February 1.
On February 1, 2024, CUREosity GmbH, the German health insurance company Techniker Krankenkasse (TK) and the Ambulanticum in Herdecke began what could be a pioneering collaboration. As part of this pilot project, the Ambulanticum is introducing modern virtual reality therapy as a new therapy component in its treatment concept. An outstanding feature of this project is the first reimbursement of CUREO® VR therapy for patients by a statutory health insurance provider in Germany.
Customized solutions for patients
The Ambulanticum offers interdisciplinary intensive therapy for severely affected patients with neurological diseases and specializes in late aftercare. Caesar van Heyningen, CEO of CUREosity, emphasizes the importance of this collaboration: "We couldn't wish for better partners for this first pilot. The Techniker and the Ambulanticum have both set themselves the goal of providing patients with the most modern and effective therapy. We are delighted that patients at the Ambulanticum will benefit from virtual reality therapy with CUREO® and see this as an important step towards giving even more patients access to innovative therapy with CUREO® in the future."
TK sees itself as a pioneer for innovative healthcare solutions and attaches great importance to finding individual solutions for its policyholders. Barbara Steffens, head of TK's NRW regional office, emphasizes the importance of pilot projects such as this one in integrating innovative therapy methods into existing care structures.
Combining proven therapies with modern approaches
The Ambulanticum, founded by Dr. Bernd Krahl and his wife Marion Schrimpf, places a strong focus on modern therapy methods. The team in Herdecke combines proven forms of therapy with innovative approaches such as CUREO® VR therapy to offer patients a broad and effective range of treatments.
The cooperation between TK, the Ambulanticum and CUREosity is initially limited to one year. CUREosity will accompany the project and conduct a qualitative survey to investigate the motivation and feasibility of the project.